Clinical trials for Hodgkin lymphoma
14 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ACTIVE NOT RECRUITINGNCT07374068Prognostic Model of Elderly Hodgkin Lymphoma in ChinaTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNCT07356882European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin LymphomaAssistance Publique - Hôpitaux de Paris · PI: Mathieu SIMONIN, MD
- RECRUITINGPhase 2NCT06848569Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II StudySun Yat-sen University
- RECRUITINGPHASE2, PHASE3NCT06563245Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT AssessmentChildren's Cancer Group, China · PI: YI JIN GAO, MD
- RECRUITINGPhase 2NCT04838652Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin LymphomaUniversity of Cologne · PI: Andreas Engert, Prof.
- RECRUITINGPhase 2NCT05900765A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's LymphomaSun Yat-sen University · PI: Zhiming Li
- RECRUITINGNCT06822855Changing Paragidms In The Prognostic Assessment Of Hodgkin LymphomaAzienda USL Reggio Emilia - IRCCS · PI: Luminari Stefano, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04640779Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple MyelomaMayo Clinic · PI: Jonas Paludo, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04268706Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)Tessa Therapeutics · PI: Helen Heslop, MD
- RECRUITINGN/ANCT06883604Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-HodgkinUppsala University Hospital · PI: Daniel Molin, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT03337919ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin LymphomaUniversity College, London · PI: Graham Collins
- ACTIVE NOT RECRUITINGPhase 2NCT02940301Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin LymphomaOhio State University Comprehensive Cancer Center · PI: Lapo Alinari, MD, PhD
- ACTIVE NOT RECRUITINGPhase 3NCT02661503HD21 for Advanced StagesUniversity of Cologne · PI: Peter Borchmann, Prof.
- RECRUITINGNCT01790152Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentChildren's Oncology Group · PI: Eric J Chow